July 7, 2025

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatile Path with a $11.37 Billion Market Cap

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), is capturing attention in the healthcare sector, especially within the niche of drug manufacturing..

Natera, Inc. (NTRA) Investor Outlook: Analyzing the 19.18% Potential Upside in Healthcare Diagnostics

Natera, Inc. (NASDAQ: NTRA) stands at the forefront of the healthcare diagnostics sector, offering a suite of innovative molecular testing services that cater to a global clientele. With a market..

Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Gem with 22% Upside Potential

Waystar Holding Corp. (NASDAQ: WAY) is capturing the attention of investors in the healthcare sector with its robust cloud-based software solutions for healthcare payments. As the company navigates a burgeoning..

BioNTech SE (BNTX) Stock Analysis: Exploring Growth Potential with a 24.61% Upside

BioNTech SE (NASDAQ: BNTX), headquartered in Mainz, Germany, is a prominent player in the biotechnology sector, known for its groundbreaking contributions to immunotherapy for cancer and infectious diseases. As the..

Royalty Pharma plc (RPRX) Stock Analysis: Strong Analyst Consensus with a 14% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) continues to capture the interest of investors with its unique position in the biotechnology sector. As a major player in the biopharmaceutical royalties market, Royalty..

Nuvalent, Inc. (NUVL) Stock Analysis: Unveiling a 45.75% Upside Potential in the Biotech Sector

Nuvalent, Inc. (NUVL), a pioneering force in the biopharmaceutical arena, is capturing the attention of investors with its promising pipeline of cancer therapies and an impressive potential upside of 45.75%...

Insmed Incorporated (INSM) Stock Analysis: Strong Buy Ratings Signal Potential Upside in the Biotech Sector

Insmed Incorporated (NASDAQ: INSM) is making waves in the biotechnology sector with its innovative approach to treating serious and rare diseases. Headquartered in Bridgewater, New Jersey, Insmed’s growth trajectory is..

Oscar Health, Inc. (OSCR) Stock Analysis: A Healthcare Innovator with 42.2% Revenue Growth and 6.21% Potential Upside

Oscar Health, Inc. (NYSE: OSCR) has been making waves in the healthcare sector with its innovative approach to health plans and technology-driven solutions. As a company that focuses on offering..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unveiling a 109% Potential Upside for Investors

Cytokinetics, Incorporated (NASDAQ: CYTK) offers a captivating prospect for investors, with a substantial potential upside of 109.32% as per current analyst ratings. As a late-stage biopharmaceutical company, Cytokinetics focuses on..

Masimo Corporation (MASI) Stock Analysis: A 9.65% Upside Potential in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, particularly in medical devices, presents a compelling case for investors looking for growth opportunities within the industry. With a..

Blueprint Medicines Corporation (BPMC) Stock Analysis: A Biotech Challenger with 55.5% Revenue Growth

Blueprint Medicines Corporation (NASDAQ: BPMC), a rising star in the biotechnology sector, is capturing investor attention with its robust revenue growth of 55.5%. Headquartered in Cambridge, Massachusetts, this precision therapy..

RadNet, Inc. (RDNT) Stock Analysis: A Promising Prospect with 27% Potential Upside

RadNet, Inc. (NASDAQ: RDNT) stands as a formidable entity in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $4.22 billion, this Los Angeles-based company is..

GSK plc (GSK) Investment Outlook: Analyzing the 9.27% Potential Upside in the Healthcare Giant

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, stands as a pivotal player in the drug manufacturing industry, renowned for its robust portfolio of vaccines and specialty medicines...

BrightSpring Health Services, I (BTSG) Investor Outlook: Anticipating a 27% Upside with Strong Buy Ratings

For investors seeking opportunities in the healthcare sector, BrightSpring Health Services, Inc. (BTSG) presents a compelling case. Headquartered in Louisville, Kentucky, and operating in the Health Information Services industry, BrightSpring..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 12.2% Upside Potential with Promising Pipeline in B-cell Treatments

TG Therapeutics, Inc. (NASDAQ: TGTX), a biotechnology company rooted in the healthcare sector, has caught the attention of investors with its innovative approach to treating B-cell mediated diseases. With a..

Merck & Company, Inc. (MRK) Stock Analysis: Unpacking a 25.77% Potential Upside for Investors

Merck & Company, Inc. (NYSE: MRK) stands as a formidable player in the healthcare sector, renowned for its pioneering work in pharmaceuticals and animal health. With a robust market capitalization..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unpacking a 24% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology industry, is currently capturing investor attention with its impressive 24.07% potential upside, as reflected in its average target price..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating a Complex Landscape with High ROE and Growth Potential

Medpace Holdings, Inc. (NASDAQ: MEDP), a key player in the diagnostics and research sector, has carved out a significant niche within the healthcare industry. With a market capitalization of $9.24..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 9.98% Upside in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in San Juan Capistrano, California, this company..

Elanco Animal Health Incorporated (ELAN): Investor Outlook with a 1.53% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, is making waves with its focus on animal..

Search

Funds

July 7, 2025

Search

Funds

July 7, 2025

FTSE 100

Funds